Anifrolumab can substantially lower the risk for long-term organ damage progression in patients with moderate to severe ...

After a previously reported positive phase 2 trial in systemic lupus erythematosus (SLE), the TYK2 inhibitor deucravacitinib ...

Patients with cutaneous lupus erythematosus who used hydroxychloroquine had a significantly reduced risk of developing systemic lupus erythematosus.

In a new study, researchers explored experiences, perceptions, and health effects of a newly developed healthy lifestyle ...

The Lupus Foundation of America describes lupus as a chronic disease that attacks the immune system, the part of the body ...

Lupus Alert Day serves a vital purpose. It encourages others to learn more about lupus, share information on social media, ...

Kris Aquino revealed her "pain and struggle" amid suffering from lupus flare fever for over two weeks now, appealing to the ...

African Americans, particularly women, and residents of Southern states face disproportionately high rates of SLE-related mortality.

New research suggests the use of oral prednisone should be limited in patients with systemic lupus erythematosus with a history of recurrent pericarditis.

More than one-third of patients with systemic lupus erythematosus experience a flare after starting dialysis for end-stage renal disease, according to data published in Arthritis Care & Research.

A 2022 study found that just over 27% of people with systemic lupus erythematosus experience hearing loss, with 80% of cases being sensorineural hearing loss. This type of hearing loss usually ...